WAYNE, N.J.– Vision Research, a leading manufacturer of digital high-speed imaging systems, has for the first time supplied an embedded Phantom high-speed camera for use within a medical device with U.S. Food and Drug Administration (FDA) 501(k) clearance.
The device, Cytovale®’s IntelliSep® test, is a new diagnostic tool that provides clinicians with early indication of sepsis probability to support critical time-sensitive clinical decisions, providing test results in under 10 minutes and contributing to rapid life-saving decisions.
Critical to this groundbreaking diagnostic system is the Phantom VEO 710 high-speed camera, which resolves blood cells as they move through the microfluidics channel at 3 meters per second, requiring frame rates greater than 500,000 frames per second (fps). The VEO 710 employs a custom CMOS sensor with 7 Gpx/s image throughput and supports the fast offload of data, contributing to IntelliSep’s fast, 10-minute sample turnaround time. It is also a well-established camera used in a variety of industries and applications, with the proven reliability necessary for long-term success.
“Phantom VEO high-speed cameras provide valuable insights into many biological and biomedical events that are otherwise too fast to be seen,” says Toni Lucatorto, Product Manager, Vision Research. “They are a key enabling technology in flow cytometry, and we’re very excited to be part of this life-saving medical breakthrough.”
